PLUR Pluri Inc
- 6.0500
- -0.0500-0.82%
- 6.1900
- +0.1400+2.31%
Pluri Inc News
Pluri Collaborated With Wilk Technologies To Develop Human Breast Milk-derived Food Production On A Commercial Scale
Pluri Collaborated With Wilk Technologies To Develop Human Breast Milk-derived Food Production On A Commercial Scale
Pluri Inc | 10-Q: Quarterly report
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
12 Health Care Stocks Moving In Monday's After-Market Session
GainersKineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million. Moleculin Biotech (NASDAQ:MBRX) stoc
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks were easing late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each down about 0.2% The iShares Biotechnology ETF (IBB) rose 0.
Sector Update: Health Care
Health care stocks were easing late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each down 0.2% The iShares Biotechnology ETF (IBB) rose 0.2%. In
Pluri Receives US Patent for Immune Cell Expansion
Pluri (PLUR) said Monday it has received a new US patent for technology used in the expansion of immune cells. The new patent addresses challenges in allogeneic cell therapies, including limited donor
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersLongeveron (NASDAQ:LGVN) shares moved upwards by 75.0% to $3.85 during Monday's pre-market session. The market value of their outstanding shares is at $9.6 million. PetVivo Hldgs (NASDAQ:PETV)
Pluri Shares Are Trading Higher After the Company Announced That It Was Granted a New Patent Titled ""System and Methods for Immune Cells Expansion and Activation in Large Scale."
Pluri Shares Are Trading Higher After the Company Announced That It Was Granted a New Patent Titled ""System and Methods for Immune Cells Expansion and Activation in Large Scale."
Pluri Introduces Groundbreaking Immune Cell Expansion Technology, Secures New US Patent
Leading biotechnology company, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), which transforms cells into solutions that promote global wellbeing and sustainability, today unveiled a
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Pluri Inc To Carry Out 1-for-8 Reverse Stock Split On April 1st, 2024
March 28th - $Pluri Inc(PLUR.US)$ is about to implement a 1-for-8 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 1st, 2024.$Pluri Inc(PLUR.US)$ slipp
Pluri to Implement a 1-for-8 Reverse Stock Split
Pluri Inc. Announces 1-for-8 Reverse Share Split
Pluri Inc. (Nasdaq: PLUR) today announced that a reverse share split of the Company's issued and outstanding common shares, par value $0.00001 per share (the "Common Shares") at a ratio of 1-for-8 is expected to be implemented at market open on April 1, 2024.
Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report
International Coffee Organization (ICO) Market Report published on March 7, 2024 highlights alarming price instability challenging the coffee industryAccording to the report, adverse weather conditions, first noted in
Engage With Pluri's Talent: Exciting Conference Appearances Ahead
HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote
Pluri Announced That Its CDMO Division Has Signed A Manufacturing Agreement With Remedy Cell Ltd For Cell-derived Cell-free Drug Manufacturing
Pluri Announced That Its CDMO Division Has Signed A Manufacturing Agreement With Remedy Cell Ltd For Cell-derived Cell-free Drug Manufacturing
Pluri Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
HAIFA, Israel, March 11, 2024 (GLOBE NEWSWIRE) -- In a strategic move that underscores its innovative edge in the agtech sector, Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or "the Company") today
Press Release: Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to Its Advisory Board
Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board HAIFA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the "Company"), a lea
Analysis
Price Target
No Data
